These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 27808558)

  • 1. Construct Validity of the MMPI-2-RF Triarchic Psychopathy Scales in Correctional and Collegiate Samples.
    Kutchen TJ; Wygant DB; Tylicki JL; Dieter AM; Veltri COC; Sellbom M
    J Pers Assess; 2017; 99(4):408-415. PubMed ID: 27808558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further development and construct validation of MMPI-2-RF indices of global psychopathy, fearless-dominance, and impulsive-antisociality in a sample of incarcerated women.
    Phillips TR; Sellbom M; Ben-Porath YS; Patrick CJ
    Law Hum Behav; 2014 Feb; 38(1):34-46. PubMed ID: 23855322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and construct validation of MMPI-2-RF indices of global psychopathy, fearless-dominance, and impulsive-antisociality.
    Sellbom M; Ben-Porath YS; Patrick CJ; Wygant DB; Gartland DM; Stafford KP
    Personal Disord; 2012 Jan; 3(1):17-38. PubMed ID: 22448859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of MMPI-2-RF Scales for Indexing Triarchic Psychopathy Constructs.
    Sellbom M; Drislane LE; Johnson AK; Goodwin BE; Phillips TR; Patrick CJ
    Assessment; 2016 Oct; 23(5):527-43. PubMed ID: 26139828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operationalizing the triarchic model of psychopathy in adolescents using the MMPI-A-RF (Restructured Form).
    Semel RA; Pinsoneault TB; Drislane LE; Sellbom M
    Psychol Assess; 2021 Apr; 33(4):311-325. PubMed ID: 33507797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing psychopathic traits with the MMPI-3: Findings from correctional, university, and community samples.
    Wygant DB; Sellbom M
    Law Hum Behav; 2024 Feb; 48(1):1-12. PubMed ID: 38573701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of the triarchic conceptualization of psychopathy in incarcerated and nonincarcerated samples.
    Sellbom M; Phillips TR
    J Abnorm Psychol; 2013 Feb; 122(1):208-214. PubMed ID: 22867118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are fearless dominance traits superfluous in operationalizing psychopathy? Incremental validity and sex differences.
    Murphy B; Lilienfeld S; Skeem J; Edens JF
    Psychol Assess; 2016 Dec; 28(12):1597-1607. PubMed ID: 26866795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the associations between DSM-5 section III antisocial personality disorder traits and psychopathy in community and university samples.
    Anderson JL; Sellbom M; Wygant DB; Salekin RT; Krueger RF
    J Pers Disord; 2014 Oct; 28(5):675-97. PubMed ID: 24689766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the Construct Validity of the Psychopathic Personality Inventory Triarchic Scales.
    Sellbom M; Wygant DB; Drislane LE
    J Pers Assess; 2015; 97(4):374-81. PubMed ID: 25325407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent variable model of triarchic psychopathy constructs in an incarcerated offender sample: Factor reliability and validity.
    Drislane LE; Sica C; Lowman KL; Colpizzi I; Joyner KJ; Bottesi G; Patrick CJ
    Psychol Assess; 2022 Oct; 34(10):899-911. PubMed ID: 35849405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating psychopathy from antisocial personality disorder: a triarchic model perspective.
    Venables NC; Hall JR; Patrick CJ
    Psychol Med; 2014 Apr; 44(5):1005-13. PubMed ID: 23834781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elaborating on the construct validity of the Triarchic Psychopathy Measure in a criminal offender sample.
    Stanley JH; Wygant DB; Sellbom M
    J Pers Assess; 2013; 95(4):343-50. PubMed ID: 23113864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A triarchic model analysis of the youth psychopathic traits inventory.
    Drislane LE; Brislin SJ; Kendler KS; Andershed H; Larsson H; Patrick CJ
    J Pers Disord; 2015 Feb; 29(1):15-41. PubMed ID: 24932874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of the Youth Psychopathic Traits Inventory (YPI)-Triarchic Scales and the YPI in a Sample of Justice-Involved Youth.
    Ruchensky JR; Edens JF; Donnellan MB; Hawes SW; Mulvey EP
    J Pers Disord; 2020 Jun; 34(3):308-323. PubMed ID: 30307829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving characterization of psychopathy within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), alternative model for personality disorders: Creation and validation of Personality Inventory for DSM-5 Triarchic scales.
    Drislane LE; Sellbom M; Brislin SJ; Strickland CM; Christian E; Wygant DB; Krueger RF; Patrick CJ
    Personal Disord; 2019 Nov; 10(6):511-523. PubMed ID: 31259604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the Triarchic Model of psychopathy's nomological network: A meta-analytic review.
    Sleep CE; Weiss B; Lynam DR; Miller JD
    Clin Psychol Rev; 2019 Jul; 71():1-26. PubMed ID: 31078055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triarchic Psychopathy Measure: Convergent and discriminant validity in a correctional treatment setting.
    Yoon D; Mokros A; Rettenberger M; Briken P; Brunner F
    Personal Disord; 2022 Jan; 13(1):52-63. PubMed ID: 33507790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and preliminary validation of Triarchic Psychopathy Scales from the HEXACO-100.
    Marcus DK; Eichenbaum AE; Anderson AE; Zimmerman JA; Nagel MG; Zeigler-Hill V; Watts AL; Lilienfeld SO
    Psychol Assess; 2019 Aug; 31(8):961-973. PubMed ID: 30920246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the Association Between the MMPI-2-RF Triarchic Psychopathy Scales and Suicidality in a Criminal Defendant Sample.
    Tylicki JL; Sellbom M; Ben-Porath YS
    J Pers Disord; 2021 Jun; 35(3):336-354. PubMed ID: 31682193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.